HomeBLRX • TLV
add
BioLine RX Ltd
Previous close
ILA 12.30
Day range
ILA 12.00 - ILA 12.40
Year range
ILA 11.60 - ILA 44.00
Market cap
38.91M USD
Avg Volume
945.50K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 5.39M | — |
Operating expense | 10.27M | 3.57% |
Net income | 484.00K | 102.61% |
Net profit margin | 8.97 | — |
Earnings per share | — | — |
EBITDA | -5.30M | 45.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.06M | 22.08% |
Total assets | 64.60M | 9.60% |
Total liabilities | 50.62M | 33.61% |
Total equity | 13.98M | — |
Shares outstanding | 1.20B | — |
Price to book | 12.30 | — |
Return on assets | -24.84% | — |
Return on capital | -41.47% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 484.00K | 102.61% |
Cash from operations | -11.33M | -17.01% |
Cash from investing | -8.64M | -177.88% |
Cash from financing | 23.88M | 17,920.15% |
Net change in cash | 3.63M | 250.00% |
Free cash flow | -6.37M | 19.39% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
79
